Vivos jumps as device maker partners with SoundHealth to broaden sleep, allergy offerings

Shares of Medical device maker Vivos Therapeutics VVOS.O rise 10% to $1.65 premarket

Co says it will distribute SoundHealth’s sleep and allergy devices, including an FDA-cleared wearable for nasal congestion and a new band that uses sound-based therapy to help users sleep

Partnership also gives Vivos access to facial‑scanning and voice‑analysis tools to help screen patients for sleep disorders, per co

Collaboration aims to widen access to non‑invasive treatments for sleep‑related breathing issues, which are often undiagnosed, co says

Vivos develops devices for sleep apnea; SoundHealth builds AI‑powered health tools

Shares down ~53% in 2025